menu
    • menu

    Company profile for Glyscend Therapeutics

    NEW Drugs in Dev: 1
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Developer of oral, gut-targeted polymer therapeutics intended for the treatment of metabolic indications such as type 2 diabetes, and other chronic conditions. The company is developing a lead drug, which is orally administered, non-absorbed, gut-restricted duodenal exclusion therapy designed to replicate the metabolic effects of bariatric surgery with safety advantages, enabling patients to avoid invasive complications of sur...
    Developer of oral, gut-targeted polymer therapeutics intended for the treatment of metabolic indications such as type 2 diabetes, and other chronic conditions. The company is developing a lead drug, which is orally administered, non-absorbed, gut-restricted duodenal exclusion therapy designed to replicate the metabolic effects of bariatric surgery with safety advantages, enabling patients to avoid invasive complications of surgeries and procedures.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Glyscend TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1812 Ashland Avenue Suite 110 Baltimore, MD 21205
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.glyscend.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/glyscend-incorporated/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/glyscend

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Glyscend Doses First GLY-200 Obesity Phase 2 Patient
    Glyscend Doses First GLY-200 Obesity Phase 2 Patient

    03 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240603545689/en

    BUSINESSWIRE
    03 Jun 2024
    Share Share
    Glyscend Appoints Sapan A. Shah Accomplished Industry Executive, as CEO
    Glyscend Appoints Sapan A. Shah Accomplished Industry Executive, as CEO

    05 Sep 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230905675993/en

    BUSINESSWIRE
    05 Sep 2023
    Share Share
    Glyscend Announces Positive Topline Phase 2a Clinical Results of GLY-200
    Glyscend Announces Positive Topline Phase 2a Clinical Results of GLY-200

    31 May 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230531005626/en

    BUSINESSWIRE
    31 May 2023
    Share Share
    Glyscend Therapeutics' early data show polymer mimics benefits
    Glyscend Therapeutics' early data show polymer mimics benefits

    31 May 2023

    // Katherine Lewin ENDPTS

    https://endpts.com/glyscend-therapeutics-touts-polymer-that-mimics-benefits-of-surgery-in-type-2-diabetes-obesity/

    Katherine Lewin ENDPTS
    31 May 2023
    Share Share
    Glyscend Appoints Biotech Industry Veteran Michael Wyzga to Board of Directors
    Glyscend Appoints Biotech Industry Veteran Michael Wyzga to Board of Directors

    30 Mar 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230330005094/en

    BUSINESSWIRE
    30 Mar 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search